| Application no. and date | 16154916.7 (espacenet) (Federated) (European Patent Register), 20010605 | | Patent/reg. no. and date | DK/EP 3059314, 20181024 | | Publication date | 20160824 | | Priority no. and date | GB 0013810, 20000606 | | EP pub. no. and date |
EP 3059314 20160824 | | Effective date | | | Applicant/owner | UCB Pharma, S.A., Allée de la Recherche 60
1070 Bruxelles, BE | | Applicant ref. no. | 162214 | | Inventor | Athwal, Diljeet Singh, c/o Intellectual Property Dpt
UCB Celltech Ltd.
208 Bath Road
Slough
Berkshire SL1 3WE, GB,
Brown, Derek Thomas, c/o Intellectual Property Dpt
UCB Celltech Ltd.
208 Bath Road
Slough
Berkshire SL1 3WE, GB,
Weir, Andrew Neil Charles, c/o Intellectual Property Dpt
UCB Celltech Ltd.
208 Bath Road
Slough
Berkshire SL1 3WE, GB,
Popplewell, Andrew George, c/o Intellectual Property Dpt
UCB Celltech Ltd.
208 Bath Road
Slough
Berkshire SL1 3WE, GB,
Chapman, Andrew Paul, c/o Intellectual Property Dpt
UCB Celltech Ltd.
208 Bath Road
Slough
Berkshire SL1 3WE, GB,
King, David John, c/o Intellectual Property Dpt
UCB Celltech Ltd.
208 Bath Road
Slough
Berkshire SL1 3WE, GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 47/68 (2017.01) , C07K 16/24 (2006.01) , C12N 15/13 (2006.01) | | Title | ANTISTOFMOLEKYLER, DER HAR SPECIFICITET FOR HUMAN TUMORNEKROSEFAKTOR ALPHA, OG ANVENDELSE DERAF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2019 00019 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
